Walter Ling, M.D.
Studies associated with:
Division | Study Number | Title | Investigator(s) | Release Date |
---|---|---|---|---|
CTN | NIDA-CTN-0054 | Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT) | Walter Ling, M.D. | |
CTN | NIDA-CTN-0048 | Cocaine Use Reduction with Buprenorphine (CURB) | Walter Ling, M.D. | |
CTN | NIDA-CTN-0030 | A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence | Walter Ling, M.D., Roger Weiss, M.D. | |
CTN | NIDA-CTN-0027 | Starting Treatment with Agonist Replacement Therapies (START) | Walter Ling, M.D. | |
CTN | NIDA-CTN-0003 | Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Two Schedules | Walter Ling, M.D. | |
CTN | NIDA-CTN-0002 | Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification | Walter Ling, M.D. | |
CTN | NIDA-CTN-0001 | Buprenorphine/Naloxone versus Clonidine for Inpatient Opiate Detoxification | Walter Ling, M.D. | |
DTMC | NIDA-CSP-1018 | A Multicenter Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence | Walter Ling, M.D., Paul J. Fudala, Ph.D., Paul Casadonte, M.D. | |
DTMC | NIDA-CSP-999 | A Multicenter Clinical Trial of Buprenorphine in Treatment of Opiate Dependence | Walter Ling, M.D., Donald R. Wesson, M.D., C. James Klett, Ph.D. |